Shanghai RAAS Blood Products Co., Ltd. (SZSE: 002252)
Health Care · Biotechnology · CN
CN¥5.32
+5.98% today · -21.5% 1Y
Shanghai RAAS Blood Products Co., Ltd. (SZSE: 002252) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.23B and employs 4,045 people.
Over the last twelve months the share price has lost 21.5%, trading between 4.18 and 6.97.
Tweenvest scores Shanghai RAAS Blood Products Co., Ltd. across four factors: quality 66/100, value 47/100, growth 44/100, dividend 16/100. Its strongest factor is quality.
002252 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.23B
- Revenue (TTM)
- $972.42M
- P/E
- 28.89
- EPS
- 0.18
- Dividend yield
- 0.91%
- Beta (5Y)
- 0.27
- 52-week high
- CN¥6.97
- 52-week low
- CN¥4.18
- Avg volume (3M)
- —
- Shares outstanding
- 6.59B
- Employees
- 4,045
- Next earnings
- —
About Shanghai RAAS Blood Products Co., Ltd.
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
- ISIN
- CNE100000C31
- Founded
- 1988
- Listed since
- Jun 23, 2008
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc.NasdaqGM: MIRM | $5.38B | $79.47 | -4.18% |
| Travere Therapeutics, Inc.NasdaqGM: TVTX | $5.37B | $51.91 | -8.82% |
| PTC Therapeutics, Inc.NasdaqGS: PTCT | $5.28B | $61.87 | -2.15% |
| Cogent Biosciences, Inc.NasdaqGS: COGT | $5.23B | $28.99 | -3.82% |
| Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.SHSE: 603392 | $5.15B | CN¥27.34 | +3.64% |
| Scholar Rock Holding CorporationNasdaqGS: SRRK | $5.14B | $42.20 | 0.00% |
| CRISPR Therapeutics AGNasdaqGM: CRSP | $5.06B | $51.07 | -2.45% |
| Chongqing Zhifei Biological Products Co., Ltd.SZSE: 300122 | $4.99B | CN¥13.98 | +7.46% |
Figures last refreshed Oct 4, 2026.